top of page

RECHARGE UNIVERSITY

RECHARGE
Health & Wellness

Parkinson's disease

Parkinson's disease OVERVIEW

Parkinson's disease (PD) is a type of movement disorder. It happens when nerve cells in the brain don't produce enough of a brain chemical called dopamine. Sometimes it is genetic, but most cases do not seem to run in families. Exposure to chemicals in the environment might play a role.  symptoms begin gradually, often on one side of the body. Later they affect both sides. They include trembling of hands, arms, legs, jaw and face, stiffness of the arms, legs.

​

Therapy is NOT a cure but designed to improve our clients quality of life.

​

THERAPY OVERVIEW

Parkinson’s disease (PD) is a neurodegenerative condition, predominantly affecting older adults. Preference-based measures Photobiomodulation can be used to make decisions about the cost-utility of different treatments and quality of life benefits. A previous study identified important health domains for individuals with PD and developed an item pool from existing measures of quality of life.  Fifty-three participants completed a visual analogue scale (VAS) of self-perceived health, the prototype PBM measure, and an item importance rating. To reduce the item pool, the following were calculated: (1) inter-item correlations; (2) impact of each item based on item performance and importance rating; (3) directionality of response options by comparing the VAS scores against each item. Results. Participants (male = 54.7%, age = 60.0 ± 10.2) had a median Hoehn and Yahr score of 2.5 (interquartile range = 1). Items supported for inclusion by this analysis were sleep, fatigue, tremor, mood, walking, memory, and dexterity. Items demonstrating a logical decrease in VAS score with each increasing severity level were sleep, memory, tremor, fatigue, and mood.

​

SCIENTIFIC BACKED RESULTS

​

Improvements in clinical signs of Parkinson's disease using photobiomodulation: A prospective proof-of-concept study
A Liebert, B Bicknell, E Laakso… - Bmc …, 2021 - bmcneurol.biomedcentral.com

​

Mitochondrial dysfunction and Parkinson's disease—Near-infrared photobiomodulation as a potential therapeutic strategy
ASC Foo, TW Soong, TT Yeo, KL Lim - Frontiers in Aging …, 2020 - frontiersin.org

 

Progress of Photobiomodulation for Parkinson's Disease
CM Tsai - SOJ Complement Emerg Med, 2022 - stephypublishers.com

​

Effects of transcranial pulsed electromagnetic field stimulation on quality of life in Parkinson's disease
BM Morberg, AS Malling, BR Jensen… - European Journal of …, 2018 - Wiley Online Library

 

 

effectiveness

Pulsed electromagnetic fields induce a protective and anti-inflammatory effect in the nervous system primarily due to growth factor upregulation that possibly abates neurodegeneration in Parkinson's disease (PD). Te study investigated treatment effects of transcranial pulsed electromagnetic fields (T-PEMFs) on quality of life in PD and the feasibility and safety of this treatment.  A double-blinded clinical study, 97 participants with idiopathic PD, on optimal medical anti-parkinsonian treatment, were block randomized (3:3) to either active (n = 49) or placebo treatment (n = 48). Treatment with T-PEMFs entailed one daily 30-min home treatment for eight consecutive weeks. The active group improved with respect to clinical effect size for the two dimensions, i.e. mobility and activities of daily living, compared with the placebo group.  Treatment with T-PEMFs improved mobility and activities of daily living scores for clinical effect size only in the active group, indicating a positive treatment response for motor symptoms.

BM Morberg, AS Malling, BR Jensen… - European Journal of …, 2018 - Wiley Online Library

​

HOW OFTEN

How often should you repeat this therapy? The Parkinson's therapy program at Recharge requires a once per week visit to the club for 30-90 minutes per session.

 

RESULTS

What are the results of this therapy?  After approximately 6-8 weeks clients should see a noticeable improvement

 

​

​

 

bottom of page